潜江永安药业股份有限公司2025年第二次临时股东会决议公告

Meeting Overview - The second extraordinary general meeting of shareholders for 2025 was held on October 15, 2025, at 14:30, combining on-site and online voting methods [1][2] - A total of 525 shareholders attended the meeting, representing 77,902,515 shares, which is 26.9424% of the total voting shares [3][4] Voting Results - The proposal to change the business scope, increase the number of board members, and amend the Articles of Association was approved with 99.7578% of the votes in favor, totaling 77,713,815 shares [6][8] - The proposal to amend the governance system was also approved, with 99.7528% of the votes in favor for the amendment of the Shareholders' Meeting Rules [9][11] - The proposal to revise the Board Meeting Rules received 99.7434% approval [12][14] - The proposal to amend the Independent Director Work System was approved with 99.7558% of the votes in favor [15][17] Legal Compliance - The meeting's procedures, including the convening, attendance, and voting, were confirmed to comply with relevant laws and regulations by the witnessing lawyers from Shanghai Jintiancheng (Wuhan) Law Firm [17]